Safety
?
-
Depo-Medrol (methylprednisolone acetate injectable suspension, USP)
Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) -- April 2009
| The detailed view includes drug products with safety labeling changes to the BOXED WARNING, CONTRAINDICATIONS, WARNINGS, PRECAUTIONS, ADVERSE REACTIONS, or PATIENT PACKAGE INSERT/MEDICATION GUIDE sections. Deletions or editorial revisions made to these sections are not included in this summary. Read about the new physician labeling format. |
| Sections Modified |
Summary of Changes to Contraindications and Warnings |
|
Entire Label Revision; sections are rearranged and the terminology revised for some of the diseases/conditions
WARNINGS
PRECAUTIONS
DRUG INTERACTIONS
ADVERSE REACTIONS
|
WARNINGS
PRECAUTIONS
DRUG INTERACTIONS
ADVERSE REACTIONS
|
-
-
